Evidence map›Paper›PMID 33996574›Full record

ArticleFrontiers in oncology2021

Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p.

Danhui Ma, Sinuo Chen, Heming Wang, Jiayi Wei, Hao Wu, Hong Gao, Xinlai Cheng, Taotao Liu, Shi-Hua Luo, Yicheng Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Frontiers in pharmacology · 2024
    Review
  16. Article
  17. Article
  18. The roles of ING5 in cancer: A tumor suppressor.Frontiers in cell and developmental biology · 2022
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Danhui MaDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Sinuo ChenDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Heming WangDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Jiayi WeiDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Hao WuDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Hong GaoDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Xinlai ChengBuchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Frankfurt, Germany.
Taotao LiuDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Shi-Hua LuoDepartment of Traumatology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yicheng ZhaoClinical Medical College, Changchun University of Chinese Medicine, Changchun, China.
Guangqi SongDepartment of Gastroenterology and Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.
Shanghai Institute of Hematology · CNFudan University · CNChangchun University of Chinese Medicine · CNGoethe University Frankfurt · DEShanghai Jiao Tong University · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is a common malignant tumor with a high incidence and mortality rate. The prognosis of patients with pancreatic cancer is considerably poor due to the lack of effective treatment in clinically. Despite numerous studies have revealed that baicalein, a natural product, is responsible for suppressing multiple cancer cells proliferation, motility and invasion. The mechanism by which baicalein restraining pancreatic cancer progression remains unclear. In this study, we firstly verified that baicalein plays a critical role in inhibiting pancreatic tumorigenesis

Indexed as

apoptosisbaicaleinhigh-throughput sequencingmicroRNApancreatic cancer

Identifiers

PMID33996574
PMCPMC8120266
OpenAlexW3159090549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.